Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase

Clinical trial NCT06961201 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06961201
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Extensive-stage Small Cell Lung Cancer (ES-SCLC)The Pre-cachexia or Cachexia Patients Who Have Not Received Systemic Treatment and Are Not Eligible for Curative Therapy

Start date: 2025-05-01
Primary completion: 2026-12-31
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.